PropertyValue
?:abstract
  • Aim of this paper is to remind the risk of ototoxicity when using chloroquine and hydroxychloroquine, in particular as prophylactic agents against SARS-CoV-2, during the pandemic. Healthy subjects taking chloroquine and hydroxychloroquine as prophylactic agents against SARS-CoV-2, during the pandemic, should be screened periodically, at least by Otoacoustic Emissions (OAEs) in order to detect early manifestations of possible cochlear ototoxic damages.
is ?:annotates of
?:creator
?:journal
  • J_Glob_Antimicrob_Resist
?:license
  • unk
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:source
  • WHO
?:title
  • Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency
?:type
?:who_covidence_id
  • #866871
?:year
  • 2020

Metadata

Anon_0  
expand all